ArticleJournal of neurology2019
Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
Michael Guger et al.PubMed ↗Publisher ↗
No numbers read from the abstract.